Selley Michael L
Angiogen Pharmaceuticals Pty. Ltd., P.O. Box 512, Turramurra, N.S.W. 2074, Australia.
J Affect Disord. 2004 Jun;80(2-3):249-56. doi: 10.1016/S0165-0327(03)00135-6.
(E)-4-Hydroxy-2-nonenal (HNE) is a highly electrophilic end-product of lipid peroxidation. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial nitric oxide synthase (NOS). ADMA is metabolised by dimethylarginine dimethylaminohydrolase (DDAH). DDAH contains a nucleophilic cysteine residue in its active site. There is an increase in lipid peroxidation in major depression. Major depression is associated with the development of coronary heart disease (CHD) and greatly increases morbidity and mortality. There is an increase in circulating ADMA in CHD and vascular risk factors.
To determine plasma HNE, ADME and nitric oxide (NO) concentrations in patients with major depression compared to normal volunteers and to examine the effect of HNE on ADMA formation and DDAH activity in cultured endothelial cells.
The study was conducted in 25 patients with major depression (DSM-IV criteria) and 25 healthy control subjects. Plasma concentrations of HNE were determined as the O-pentafluorylbenzyl oxime using capillary column GC-MS and deuterated HNE as the internal standard; ADME by LC-MS-MS using 13C6-L-arginine as the internal standard; and NO by GC-MS following reduction to nitrate and nitrite and derivatisation to the pentafluorobenzyl derivative using [15N]nitrate and [15N]nitrite as the internal standards. Human umbilical vein endothelial cells were incubated in serum-free medium in the presence of HNE. The concentration of ADMA in the medium was determined by LC-MS-MS. DDAH activity was determined by measuring L-citrulline in endothelial cell lysates using LC-MS.
There was a significant increase in the plasma concentration of HNE (P<0.0001) and ADMA (P<0.0002) in patients with major depression. There was a significant decrease in the plasma concentration of NO (P<0.0001). A significant positive correlation was found between the plasma concentrations of HNE and ADMA (r=0.63, P<0.0001). A significant negative correlation was detected between the plasma concentrations of ADMA and NO (r=-0.595, P<0.0001). HNE significantly increased ADMA formation (P<0.0001) and significantly decreased DDAH activity (P<0.0001) in cultured endothelial cells. The effects of HNE on DDAH activity were significantly attenuated by the addition of glutathione (P<0.0001).
No allowance was made for the phase of the menstrual cycle which could influence plasma nitric oxide concentrations.
There is an increase in circulating HNE in major depression. HNE inactivates the cysteine residue in the active site of endothelial DDAH leading to the accumulation of ADMA in the circulation. The ADMA then decreases the production of eNOS. This could reduce the amount of NO diffusing from cerebral blood vessels to nearby neurons and influence the release of neurotransmitters. ADMA also constricts cerebral blood vessels and may contribute to the decreased regional perfusion in major depression. The accumulation of ADMA could explain the increased risk of CHD in major depression. The preservation of DDAH activity and the reduction of ADMA accumulation may represent a novel therapeutic approach to the treatment of major depression.
(E)-4-羟基-2-壬烯醛(HNE)是脂质过氧化的一种高度亲电的终产物。不对称二甲基精氨酸(ADMA)是内皮型一氧化氮合酶(NOS)的内源性抑制剂。ADMA由二甲基精氨酸二甲胺水解酶(DDAH)代谢。DDAH在其活性位点含有一个亲核半胱氨酸残基。重度抑郁症患者存在脂质过氧化增加的情况。重度抑郁症与冠心病(CHD)的发生相关,且大大增加了发病率和死亡率。冠心病和血管危险因素患者的循环ADMA水平升高。
与正常志愿者相比,测定重度抑郁症患者血浆中HNE、ADMA和一氧化氮(NO)的浓度,并研究HNE对培养的内皮细胞中ADMA形成和DDAH活性的影响。
该研究纳入了25例重度抑郁症患者(符合DSM-IV标准)和25名健康对照者。采用毛细管柱气相色谱-质谱联用仪,以O-五氟苄基肟测定血浆HNE浓度,氘代HNE作为内标;采用液相色谱-串联质谱联用仪,以13C6-L-精氨酸作为内标测定ADMA;通过气相色谱-质谱联用仪,将其还原为硝酸盐和亚硝酸盐,并用[15N]硝酸盐和[15N]亚硝酸盐作为内标衍生为五氟苄基衍生物后测定NO。将人脐静脉内皮细胞在含HNE的无血清培养基中孵育。采用液相色谱-串联质谱联用仪测定培养基中ADMA的浓度。通过液相色谱法测定内皮细胞裂解物中的L-瓜氨酸来测定DDAH活性。
重度抑郁症患者血浆HNE浓度(P<0.0001)和ADMA浓度(P<0.0002)显著升高。血浆NO浓度显著降低(P<0.0001)。血浆HNE浓度与ADMA浓度之间存在显著正相关(r=0.63,P<0.0001)。血浆ADMA浓度与NO浓度之间存在显著负相关(r=-0.595,P<0.0001)。HNE显著增加培养的内皮细胞中ADMA的形成(P<0.0001),并显著降低DDAH活性(P<0.0001)。添加谷胱甘肽后,HNE对DDAH活性的影响显著减弱(P<0.0001)。
未考虑可能影响血浆一氧化氮浓度的月经周期阶段。
重度抑郁症患者循环HNE水平升高。HNE使内皮DDAH活性位点中的半胱氨酸残基失活,导致ADMA在循环中蓄积。然后ADMA减少eNOS的产生。这可能会减少从脑血管扩散到附近神经元的NO量,并影响神经递质的释放。ADMA还会使脑血管收缩,可能导致重度抑郁症患者局部灌注减少。ADMA的蓄积可以解释重度抑郁症患者冠心病风险增加的原因。保留DDAH活性和减少ADMA蓄积可能是治疗重度抑郁症的一种新的治疗方法。